New Melanoma Drugs to Prolong Survival
Two novel melanoma drugs have produced unprecedented gains in survival in separate studies of people with melanoma, the deadliest form of skin cancer, doctors have reported.
Advanced melanoma patients taking an experimental pill, vemurafenib, developed by Roche and Daiichi Sankyo were 63 percent less likely to die than patients given chemotherapy, according to a new trial presented on Sunday at a meeting of the American Society of Clinical Oncology in Chicago.
The Roche trial included 675 patients with previously untreated, inoperable late-stage metastatic melanoma with the BRAF mutation.
Video report:
Loading...